01 Increasing Adoption of Thulium Fiber Lasers for Stone Treatment The urology laser market is shifting beyond conventional holmium:YAG systems toward thulium fiber laser (TFL) technology for endoscopic stone treatment. TFL provides urologists with another laser platform for fragmentation and dusting during flexible ureteroscopy, while current clinical guidance recognizes both Ho:YAG and TFL as effective laser systems for flexible ureteroscopy. This is increasing the importance of laser platforms that can provide efficient stone disintegration while supporting different procedural techniques. In 2026, the European Association of Urology updated its Urolithiasis Guidelines and continued to recommend either Ho:YAG or thulium fiber laser lithotripsy for flexible ureteroscopy, reflecting the growing clinical role of both technologies.
02 Expansion of Laser Applications From Lithotripsy to Prostate Procedures The urology laser market is increasingly characterized by applications across both urinary stone management and benign prostatic obstruction. Laser platforms are being used for lithotripsy, prostate vaporization, and anatomical enucleation, allowing healthcare facilities to deploy laser technology across multiple urological procedures. This broader application base is increasing the value of versatile systems, compatible fibers, and technologies that can support different surgical techniques. In July 2025, the FDA cleared Boston Scientific's Flexiva Pulse laser fibers through the 510(k) pathway, with the submission reviewed by the Gastroenterology/Urology panel, reinforcing continued development of laser fiber technologies for urological procedures.
01 Increasing Use of Endoscopic Laser Lithotripsy Supports Urology Laser Demand The continued use of ureteroscopy for urinary stone treatment is increasing demand for intracorporeal laser systems. Flexible ureteroscopy requires effective stone fragmentation and dusting within the urinary tract, making laser energy an important component of modern endourological procedures. As clinicians use ureteroscopic approaches across different stone locations and sizes, demand for reliable laser generators and compatible delivery fibers is supported.
01 High Equipment and Training Requirements Can Limit Laser Adoption Urology laser systems require specialized capital equipment, compatible laser fibers, safety infrastructure, and trained clinicians. The technical learning curve can also affect procedural performance, particularly for advanced techniques such as HoLEP and ThuLEP. These equipment, training, and operational requirements can make adoption more difficult for smaller hospitals and facilities with limited urological procedure volumes.
01 Growth of Laser Enucleation Creates Opportunities for Multi-Application Systems The increasing use of laser enucleation for benign prostatic obstruction creates opportunities for manufacturers to supply systems that can support both prostate surgery and stone treatment. HoLEP and ThuLEP provide size-independent surgical options, while thulium-based technologies can also be used for vaporization and vapoenucleation. Platforms capable of supporting multiple procedures can therefore improve equipment utilization and broaden their addressable hospital customer base.
01 Managing Laser Energy, Irrigation, and Tissue Temperature Complicates Procedure Optimization Higher laser power can improve stone fragmentation efficiency and reduce procedural time, but laser energy also introduces thermal and pressure-management considerations during endoscopic procedures. Adequate irrigation, outflow, access-sheath design, and appropriate laser settings must be coordinated to maintain visualization while limiting temperature and intrarenal pressure increases. This makes system design and procedural technique important factors in safe and consistent laser use.
March 2026 Boston Scientific expanded its urology laser technology portfolio with advanced laser systems designed to improve minimally invasive treatments for urinary stones and prostate conditions.
September 2025 Olympus introduced enhanced urology laser solutions featuring improved precision and procedural efficiency for endoscopic urological procedures.
May 2025 Richard Wolf expanded its urological technology portfolio with advanced laser and endoscopic solutions supporting minimally invasive urology treatments.